Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP609576.RAntgRA4gdng64xVZIba_dO-KR0j5aIJy04xGBZGhzi6k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP609576.RAntgRA4gdng64xVZIba_dO-KR0j5aIJy04xGBZGhzi6k130_assertion type Assertion NP609576.RAntgRA4gdng64xVZIba_dO-KR0j5aIJy04xGBZGhzi6k130_head.
- NP609576.RAntgRA4gdng64xVZIba_dO-KR0j5aIJy04xGBZGhzi6k130_assertion description "[Glucose over-utilization through the polyol pathway has been linked to tissue-based pathologies associated with diabetes complications, which make the development of a potent aldose reductase inhibitor an obvious and attractive strategy to prevent or delay the onset and progression of the complications.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP609576.RAntgRA4gdng64xVZIba_dO-KR0j5aIJy04xGBZGhzi6k130_provenance.
- NP609576.RAntgRA4gdng64xVZIba_dO-KR0j5aIJy04xGBZGhzi6k130_assertion evidence source_evidence_literature NP609576.RAntgRA4gdng64xVZIba_dO-KR0j5aIJy04xGBZGhzi6k130_provenance.
- NP609576.RAntgRA4gdng64xVZIba_dO-KR0j5aIJy04xGBZGhzi6k130_assertion SIO_000772 17497245 NP609576.RAntgRA4gdng64xVZIba_dO-KR0j5aIJy04xGBZGhzi6k130_provenance.
- NP609576.RAntgRA4gdng64xVZIba_dO-KR0j5aIJy04xGBZGhzi6k130_assertion wasDerivedFrom befree-2016 NP609576.RAntgRA4gdng64xVZIba_dO-KR0j5aIJy04xGBZGhzi6k130_provenance.
- NP609576.RAntgRA4gdng64xVZIba_dO-KR0j5aIJy04xGBZGhzi6k130_assertion wasGeneratedBy ECO_0000203 NP609576.RAntgRA4gdng64xVZIba_dO-KR0j5aIJy04xGBZGhzi6k130_provenance.